✦ LIBER ✦

Enhanced CML stem cell elimination in vitro by bryostatin priming with imatinib mesylate

✍ Scribed by Heather G. Jørgensen; Elaine K. Allan; Joanne C. Mountford; Linda Richmond; Simon Harrison; Moira A. Elliott; Tessa L. Holyoake

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Stable molecular remission induced by im

✍ Wassmann, B; Scheuring, U; Thiede, C; Pfeifer, H; Bornhäuser, M; Griesinger, F; 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Effective Targeting of Quiescent Chronic

✍ Bin Zhang; Adam C. Strauss; Su Chu; Min Li; Yinwei Ho; Keh-Dong Shiang; David S. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 1021 KB

Safety and efficacy of STI-571 (imatinib

✍ Fischer, T; Reifenrath, C; Hess, G R; Corsetti, M T; Kreil, S; Beck, J; Meinhard 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 253 KB

Inhibition of platelet-derived growth fa

✍ F. Fierro; T. Illmer; D. Jing; E. Schleyer; G. Ehninger; S. Boxberger; M. Bornhä 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB

A125: Immunomodulatory Factors Produced

✍ Bukulmez, Hulya; Bilgin, Asuman; Bebek, Gurkan; Caplan, Arnold I.; Jones, Olcay 📂 Article 📅 2014 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 37 KB

Effectively targeting treatment-naïve CM

✍ Lin, Hanyang; Chen, Min; Rothe, Katharina; Lorenzi, Matthew; Woolfson, Adrian; J 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB